Key drivers for each region include: for North America, investments in research and development, policies supporting the use of N-Acetyl-L-Thioproline, and a mature ecosystem; for Europe, demographics and an aging population, infrastructure supporting the production of N-Acetyl-L-Thioproline, and regional forecast indicating steady growth; for Asia Pacific, adoption of N-Acetyl-L-Thioproline in various industries, policies supporting trade, and a large infrastructure for production; for Latin America, investments in emerging industries, demographics and a growing population, and an improving ecosystem; and for Middle East & Africa, policies supporting trade, infrastructure development, and a growing adoption of N-Acetyl-L-Thioproline.